Bertrand Tombal, MD, PhD, is Professor of Physiology and Chair of the Division of Urology at the Université catholique de Louvain and its associated hospital, the Cliniques universitaires Saint-Luc, in Brussels, Belgium. He obtained his MD in 1990 and his PhD in 2003, both from the Université catholique de Louvain, and completed part of his science training at Johns Hopkins University in Baltimore, Maryland. Professor Tombal has both a scientific and a clinical interest in urological oncology, particularly in the areas of prostate and bladder cancer. While pursuing his PhD, he investigated the mechanisms of apoptosis in prostate cancer cells and the modulation of apoptosis by growth factors. His primary clinical interest is the treatment of the advanced stages of prostate cancer, and particularly hormonal treatment and the development of new biological agents. As Head of the Uro‐Oncology Division at the Université catholique de Louvain, he is currently coordinating several clinical trials in this research area. Professor Tombal has authored many peer‐reviewed articles and books or book chapters. He has presented at numerous national and international conferences and has been the recipient of various awards for his research in the field of urology, including the European Association of Urology Thesis Award, which he received in 2003. Professor Tombal is also a member of the Scientific Office of the European Association of Urology.

Bertrand Tombal

Université catholique de Louvain, Louvain-la-Neuve

Topic: LHRH Antagonists vs Agonists